Tuhura Biosciences Inc (HURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,314 | -8,050 | -4,596 | N/A | -17,215 |
| Depreciation Amortization | 2,195 | 1,105 | 15 | N/A | 45 |
| Other Working Capital | -2,647 | -2,456 | -2,219 | N/A | -538 |
| Other Operating Activity | 1,409 | 871 | 431 | 0 | 2,308 |
| Operating Cash Flow | $-10,357 | $-8,530 | $-6,369 | $N/A | $-15,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -232 | -232 | -232 | N/A | N/A |
| Investing Cash Flow | $-232 | $-232 | $-232 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,860 | 1,860 | 1,908 | N/A | 13,708 |
| Dividend Paid | -6 | -4 | -2 | N/A | -6 |
| Financing Cash Flow | $1,854 | $1,856 | $1,906 | $N/A | $13,702 |
| Beginning Cash Position | 11,780 | 11,780 | 11,780 | N/A | 10,537 |
| End Cash Position | 3,045 | 4,874 | 7,085 | N/A | 8,839 |
| Net Cash Flow | $-8,735 | $-6,906 | $-4,695 | $N/A | $-1,698 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,357 | -8,530 | -6,369 | N/A | -15,400 |
| Capital Expenditure | -232 | -232 | -232 | N/A | 0 |
| Free Cash Flow | -10,589 | -8,762 | -6,601 | 0 | -15,400 |